CELL INTELLIGENCE · 肿瘤细胞治疗研究

靶向 PD-1/PD-L1 和 CTLA-4 免疫检查点用于肝细胞癌治疗进展

Targeting PD-1/PD-L1 and CTLA-4 Immune Checkpoints for Therapeutic Advancement in Hepatocellular Carcinoma.

磷脂酰肌醇蛋白聚糖-3 靶向治疗肝细胞癌：生物学见解与治疗策略

Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies.

用于 CAR-T 细胞快速床旁/体内编程的可注射生物指令性微泡沫

Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells.

ROBO1 CAR-NK92 细胞中 Cbl-b 敲除增强其抗肿瘤疗效

Ablation of Cbl-b in ROBO1 CAR-NK92 Cells Enhances Their Antitumor Efficacy.

靶向磷脂酰肌醇蛋白聚糖 3 的肝细胞癌联合治疗策略：一篇综合性综述

Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review.

肝细胞癌 (HCC) 的基因治疗策略：当前格局与未来方向

Gene Therapy Strategies for Hepatocellular Carcinoma (HCC): Current Landscape and Future Directions.

编码 4-1BBL 和 IL15 的溶瘤病毒增强肝细胞癌中 TIL（肿瘤浸润淋巴细胞）过继治疗的疗效

Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC.

中晚期肝细胞癌治疗的新进展

New advances in the treatment of intermediate and advanced hepatocellular carcinoma.

γδT 细胞：在肝细胞癌免疫治疗中的作用

Gamma Delta T Cells: Role in Immunotherapy of Hepatocellular Carcinoma.

溶瘤病毒治疗中晚期实体瘤的疗效与安全性：系统评价与 meta 分析

The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis.

OVs 对中晚期实体癌的治疗有效且耐受性良好，是实体癌的一种有前景的治疗方法。